Naldecon claims disputed.
D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002744:Chlorpheniramine / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D057985:Multi-Ingredient Cold, Flu, and Allergy Medications; D010033:Otitis Media / Q000188:drug therapy*; D010656:Phenylephrine / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000627:therapeutic use*
D001559:Benzhydryl Compounds; D004338:Drug Combinations; D057985:Multi-Ingredient Cold, Flu, and Allergy Medications; C034979:chlorpheniramine, phenylephrine, phenylpropanolamine, phenyltoloxamine drug combination; D010656:Phenylephrine; D010665:Phenylpropanolamine; D002744:Chlorpheniramine